128 related articles for article (PubMed ID: 29445068)
1. Lower Plasma Levels of IL-35 in Patients with Primary Biliary Cirrhosis.
Li T; Huang Y; Liu P; Liu Y; Guo J; Zhang W; Gu M; Qian C; Deng A
Tohoku J Exp Med; 2018 Feb; 244(2):123-131. PubMed ID: 29445068
[TBL] [Abstract][Full Text] [Related]
2. Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis.
Qian C; Jiang T; Zhang W; Ren C; Wang Q; Qin Q; Chen J; Deng A; Zhong R
Cytokine; 2013 Oct; 64(1):172-80. PubMed ID: 23910013
[TBL] [Abstract][Full Text] [Related]
3. TNFSF9 expression in primary biliary cirrhosis and its clinical significance.
Xia R; Tang Y; Huang Y; Yao D; Zhou Y; Chen B; Chen Y; Chen S; Deng A; Zhong R
Cytokine; 2010 Jun; 50(3):311-6. PubMed ID: 20303781
[TBL] [Abstract][Full Text] [Related]
4. Decreased IL-35 levels in patients with immune thrombocytopenia.
Yang Y; Xuan M; Zhang X; Zhang D; Fu R; Zhou F; Ma L; Li H; Xue F; Zhang L; Yang R
Hum Immunol; 2014 Aug; 75(8):909-13. PubMed ID: 24994465
[TBL] [Abstract][Full Text] [Related]
5. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset.
Harada K; Van de Water J; Leung PS; Coppel RL; Ansari A; Nakanuma Y; Gershwin ME
Hepatology; 1997 Apr; 25(4):791-6. PubMed ID: 9096578
[TBL] [Abstract][Full Text] [Related]
6. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
7. [Increased expression of IL-9 in peripheral blood and liver tissues of patients with primary biliary cirrhosis].
Wang Q; Luo D; Sun X; Feng N; Li H; Hu J; Yang W; Ma X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1679-1682. PubMed ID: 27916102
[TBL] [Abstract][Full Text] [Related]
8. S100A12 expression in patients with primary biliary cirrhosis.
Ma D; Li X; Zhang L; Deng C; Zhang T; Wang L; Hu C; Li Y; Zhang F
Immunol Invest; 2015; 44(1):13-22. PubMed ID: 25313445
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis.
Sun Y; Zhang JY; Lv S; Wang H; Gong M; Du N; Liu H; Zhang N; Jing J; Zhou C; Zhang F; Wang Z
Tohoku J Exp Med; 2014 Dec; 234(4):255-61. PubMed ID: 25400121
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
[TBL] [Abstract][Full Text] [Related]
12. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
[TBL] [Abstract][Full Text] [Related]
13. Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
Kakumu S; Yoshioka K; Tsutsumi Y; Wakita T; Arao M
Clin Immunol Immunopathol; 1990 Jul; 56(1):54-65. PubMed ID: 2113448
[TBL] [Abstract][Full Text] [Related]
14. Circulating IL-35 in pancreatic ductal adenocarcinoma patients.
Jin P; Ren H; Sun W; Xin W; Zhang H; Hao J
Hum Immunol; 2014 Jan; 75(1):29-33. PubMed ID: 24121041
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary Cirrhosis.
Huang Q; Chu S; Yin X; Yu X; Kang C; Li X; Qiu Y
Tohoku J Exp Med; 2016 Dec; 240(4):269-275. PubMed ID: 27916760
[TBL] [Abstract][Full Text] [Related]
16. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.
Tsikrikoni A; Kyriakou DS; Rigopoulou EI; Alexandrakis MG; Zachou K; Passam F; Dalekos GN
J Hepatol; 2005 Mar; 42(3):393-9. PubMed ID: 15710223
[TBL] [Abstract][Full Text] [Related]
17. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis.
Sasaki M; Ikeda H; Sawada S; Sato Y; Nakanuma Y
J Clin Pathol; 2007 Oct; 60(10):1102-7. PubMed ID: 17158635
[TBL] [Abstract][Full Text] [Related]
18. The immune response to alkaline phosphatase and other immunogens in patients with primary biliary cirrhosis.
Harding G; McKenna R; Minuk G
Hepatogastroenterology; 2001; 48(37):66-70. PubMed ID: 11269001
[TBL] [Abstract][Full Text] [Related]
19. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis.
Martinez OM; Villanueva JC; Gershwin ME; Krams SM
Hepatology; 1995 Jan; 21(1):113-9. PubMed ID: 7806143
[TBL] [Abstract][Full Text] [Related]
20. Implication of Increased Serum IL-31 for Primary Biliary Cholangitis.
Mu N; Lin F; Jiang Z; Liang Y; Yang Z
Immunol Invest; 2021 Aug; 50(6):662-670. PubMed ID: 32613870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
